hematoporphyrin has been researched along with Recrudescence in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butruk, E; Fijuth, J; Kraszewska, E; Polkowski, M; Regula, J; Rupinski, M; Wronska, E; Zagorowicz, E | 1 |
| Bown, SG; Holstege, A; Lock, G; Messmann, H; Schölmerich, J; Szeimies, RM | 1 |
| Boyle, D; Dougherty, TJ; Goldfarb, A; Kaufman, JH; Lawrence, G; Weishaupt, KR | 1 |
| Feyh, J; Kastenbauer, E | 1 |
| Goetz, AE; Gonschior, GM; Gonschior, P; Groh, J; Höfling, B | 1 |
| Erdemci, A; Gerheuser, F; Goetz, AE; Gonschior, GM; Gonschior, P; Höfling, B; Kolbe, T; Mack, B | 1 |
| Fukuda, M; Matsumoto, N; Miyoshi, N; Nakanishi, K; Saito, H | 1 |
1 trial(s) available for hematoporphyrin and Recrudescence
| Article | Year |
|---|---|
Randomized comparison of three palliative regimens including brachytherapy, photodynamic therapy, and APC in patients with malignant dysphagia (CONSORT 1a) (Revised II).
Topics: Adult; Aged; Aged, 80 and over; Argon Plasma Coagulation; Brachytherapy; Combined Modality Therapy; Deglutition Disorders; Disease-Free Survival; Esophageal Neoplasms; Female; Hematoporphyrins; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Palliative Care; Photochemotherapy; Quality of Life; Radiation Dosage; Recurrence | 2011 |
6 other study(ies) available for hematoporphyrin and Recrudescence
| Article | Year |
|---|---|
Photodynamic therapy: a safe and effective treatment for tumor overgrowth in patients with oesophageal cancer and metal stents.
Topics: Deglutition Disorders; Esophageal Neoplasms; Esophageal Stenosis; Hematoporphyrins; Humans; Palliative Care; Photochemotherapy; Recurrence; Stents | 1995 |
Photoradiation in the treatment of recurrent breast carcinoma.
Topics: Breast Neoplasms; Female; Hematoporphyrins; Humans; Photochemistry; Photosensitivity Disorders; Recurrence; Remission, Spontaneous; Skin Neoplasms; Thorax | 1979 |
[Treatment of laryngeal papillomatosis with photodynamic laser therapy].
Topics: Adult; Antiviral Agents; Child; Dihematoporphyrin Ether; Endoscopy; Follow-Up Studies; Hematoporphyrins; Humans; Laryngeal Neoplasms; Laser Therapy; Male; Papilloma; Photochemotherapy; Recurrence; Time Factors | 1992 |
[Uptake and distribution of hematoporphyrin derivatives (HPD) in arteriosclerotic and normal vessel segments].
Topics: Arteriosclerosis; Blood Vessels; Dihematoporphyrin Ether; Fluorescence; Hematoporphyrin Photoradiation; Hematoporphyrins; Humans; In Vitro Techniques; Recurrence | 1991 |
[Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration].
Topics: Administration, Topical; Angioplasty, Balloon, Coronary; Animals; Arteries; Arteriosclerosis; Catheterization; Female; Hematoporphyrin Derivative; Hematoporphyrin Photoradiation; Hematoporphyrins; Injections, Intravenous; Male; Microscopy, Fluorescence; Rabbits; Radiation-Sensitizing Agents; Recurrence; Swine | 1991 |
Combination effect of hyperthermia and photodynamic therapy on carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Fluorescence; Hematoporphyrin Photoradiation; Hematoporphyrins; Hyperthermia, Induced; Mice; Mice, Inbred C3H; Microwaves; Neoplasm Transplantation; Photochemotherapy; Recurrence; Skin Neoplasms | 1990 |